Vimarsana
Biggest News Aggregation in the World

Page 3 - Penetration Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Penetration Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Penetration Technology Today - Breaking & Trending Today

Global Transdermal Drug Delivery System Market Report 2022: Reduced Expenses & Hospital Visits for Patients Fueling Growth - Vimarsana News

Global Transdermal Drug Delivery System Market Report 2022: Reduced Expenses & Hospital Visits for Patients Fueling Growth

/PRNewswire/ -- The "Transdermal Drug Delivery System Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering. The...

Global Transdermal Drug Delivery System Market Report 2022: Reduced Expenses & Hospital Visits for Patients Fueling Growth - Vimarsana News

Global Transdermal Drug Delivery System Market Report 2022: Reduced Expenses & Hospital Visits for Patients Fueling Growth

/PRNewswire/ -- The "Transdermal Drug Delivery System Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering. The...

Topical Drug Delivery Market worth $317.8 billion by 2027 - Exclusive Report by MarketsandMarkets - Vimarsana News

Topical Drug Delivery Market worth $317.8 billion by 2027 - Exclusive Report by MarketsandMarkets

CHICAGO, May 26, 2022 /PRNewswire/ -- According to the new market research report "Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions)

Topical Drug Delivery Market worth $317.8 billion by 2027 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Topical Drug Delivery Market worth $317.8 billion by 2027 - Exclusive Report by MarketsandMarkets™

/PRNewswire/ -- According to the new market research report "Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories),...

APTT3X™ Formulation Proves Effective in COVID-19 Brazil Clinical Trial - Vimarsana News

APTT3X™ Formulation Proves Effective in COVID-19 Brazil Clinical Trial

A non-prescription intranasal application of APTT3X™ formulation will DECREASE the risk of contracting COVID-19 by 150% . APTT3X™ is a self-administered process of swabbing the lower passages of the nose, represents a scalable preventative solution that could slow the spread of COVID-19 on a global scale” — Dr. Ernesto Cesar Pinto Leal Junior, ELJ ConsultancyROCKWALL, TEXAS, UNITED STATES, April 21, 2021 /EINPresswire.com/ -- The efficacy of the APTT3X™ formulation has been validated in a just-completed clinical trial conducted in Brazil under “Black Flag” conditions. The da...